---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-092730"
form_type: "8-K"
ticker: "CERT"
cik: "0001827090"
company_name: "Certara, Inc."
filed_at: "2026-08-07T20:20:22+00:00"
generated_at: "2026-08-07T20:21:04.540722+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Certara corrects Q2 2026 call misstatement on divested business's 2025 adjusted EBITDA

## Summary
- Corrected 2025 adjusted EBITDA for divested Regulatory and Medical Writing business: ~$17M including unallocated overhead costs, not excluding.
- Excluding unallocated corporate expense that remains with Certara, 2025 adjusted EBITDA is ~$23M.
- Misstatement appeared on Aug 4, 2026 earnings call and Q2 2026 presentation; updated presentation posted to ir.certara.com.
- Clarification has no impact on previously reported results, year-over-year comparisons, or 2026 Financial Outlook.

## SEC filing metadata
- accession: 0001104659-26-092730
- form_type: 8-K
- ticker: CERT
- cik: 0001827090
- company_name: Certara, Inc.
- filed_at: 2026-08-07T20:20:22+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1827090/000110465926092730/0001104659-26-092730-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1827090/000110465926092730/tm2622458d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-092730
- JSON: https://secwatch.observer/filing/0001104659-26-092730.json
- Plain text: https://secwatch.observer/filing/0001104659-26-092730.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.